Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kymera Therapeutics (KYMR) Prepaid Assets (2019 - 2025)

Kymera Therapeutics (KYMR) has disclosed Prepaid Assets for 7 consecutive years, with $22.9 million as the latest value for Q4 2025.

  • Quarterly Prepaid Assets rose 6.57% to $22.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $22.9 million through Dec 2025, up 6.57% year-over-year, with the annual reading at $22.9 million for FY2025, 6.57% up from the prior year.
  • Prepaid Assets for Q4 2025 was $22.9 million at Kymera Therapeutics, up from $22.6 million in the prior quarter.
  • The five-year high for Prepaid Assets was $22.9 million in Q4 2025, with the low at $4.8 million in Q2 2021.
  • Average Prepaid Assets over 5 years is $13.3 million, with a median of $12.7 million recorded in 2023.
  • The sharpest move saw Prepaid Assets soared 95.93% in 2021, then grew 0.32% in 2024.
  • Over 5 years, Prepaid Assets stood at $8.7 million in 2021, then rose by 11.39% to $9.7 million in 2022, then rose by 20.19% to $11.7 million in 2023, then soared by 84.38% to $21.5 million in 2024, then rose by 6.57% to $22.9 million in 2025.
  • According to Business Quant data, Prepaid Assets over the past three periods came in at $22.9 million, $22.6 million, and $22.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.